Exploring the Feasibility of Biowaiver Extension of BCS Class III Drugs with Site-Specific Absorption Using Gastrointestinal Simulation Technology.

about

Exploring the Feasibility of Biowaiver Extension of BCS Class III Drugs with Site-Specific Absorption Using Gastrointestinal Simulation Technology.

Item

http://www.wikidata.org/entity/Q39571388

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Exploring the Feasibility of B ...... estinal Simulation Technology.

@en

Exploring the Feasibility of B ...... estinal Simulation Technology.

@nl

type

Item

label

Exploring the Feasibility of B ...... estinal Simulation Technology.

@en

Exploring the Feasibility of B ...... estinal Simulation Technology.

@nl

prefLabel

Exploring the Feasibility of B ...... estinal Simulation Technology.

@en

Exploring the Feasibility of B ...... estinal Simulation Technology.

@nl

P1476

Exploring the Feasibility of B ...... estinal Simulation Technology.

@en

P2093

Jin Sun

http://www.w3.org/2001/XMLSchema#string

Le Sun

http://www.w3.org/2001/XMLSchema#string

Zhonggui He

http://www.w3.org/2001/XMLSchema#string

P2860

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine.

The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver?

Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards.

Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine.

Predicting the impact of physiological and biochemical processes on oral drug bioavailability.

Effects of grapefruit juice on the pharmacokinetics of acebutolol.

Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: assessment using stereospecific and nonstereospecific assays.

Intestinal permeability and its relevance for absorption and elimination.

Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters.

P2888

s13318-016-0361-2

P304

471-487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13318-016-0361-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27447171

http://www.w3.org/2001/XMLSchema#string